| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Tannaz Danesh-Seta, Fatemeh Emami, Mohammad Hossein Nasr-Esfahani, Kamran Ghaedi, Mehdi Aliomran. Bee Venom-Derived BBB Shuttle and its Correlation with Oligodendrocyte Proliferation Markers in Mice Model of Multiple Sclerosis. Neurotoxicity research. vol 39. issue 4. 2021-07-13. PMID:33871814. |
this study highlights the potential therapeutic effects of apamin as a bee venom-derived peptide on oligodendrocyte precursor proliferation and elevation in myelin content in an oxidative induced multiple sclerosis model due to cuprizone exposure. |
2021-07-13 |
2023-08-13 |
mouse |
| Bo Chen, Chuan Qin, Suqiong Ji, Daishi Tian, Min Zhang, Bitao B. Modified models to distinguish central nervous system demyelinating diseases with brain lesions. Multiple sclerosis and related disorders. vol 52. 2021-07-06. PMID:33905981. |
brain lesions in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) are indistinguishable from those with relapsing-remitting multiple sclerosis (rrms) and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (aqp4-ab nmosd). |
2021-07-06 |
2023-08-13 |
Not clear |
| Samuel B Marcucci, Mohamed Elkasaby, Rosemarie Walch, Ameneh Zare-Shahabadi, Abdelkader Mahammedi, Hesham Abboud, Aram Zabet. Progressive myelopathy in myelin oligodendrocyte glycoprotein antibody-associated disease: A new mimicker of progressive multiple sclerosis? Multiple sclerosis and related disorders. vol 52. 2021-07-06. PMID:33915519. |
progressive myelopathy in myelin oligodendrocyte glycoprotein antibody-associated disease: a new mimicker of progressive multiple sclerosis? |
2021-07-06 |
2023-08-13 |
Not clear |
| Fatemeh Mohammadi-Milasi, Karim Mahnam, Mostafa Shakhsi-Niae. In silico study of the association of the HLA-A*31:01 allele (human leucocyte antigen allele 31:01) with neuroantigenic epitopes of PLP (proteolipid protein), MBP (myelin basic protein) and MOG proteins (myelin oligodendrocyte glycoprotein) for studying the multiple sclerosis disease pathogenesis. Journal of biomolecular structure & dynamics. vol 39. issue 7. 2021-07-02. PMID:32242486. |
in silico study of the association of the hla-a*31:01 allele (human leucocyte antigen allele 31:01) with neuroantigenic epitopes of plp (proteolipid protein), mbp (myelin basic protein) and mog proteins (myelin oligodendrocyte glycoprotein) for studying the multiple sclerosis disease pathogenesis. |
2021-07-02 |
2023-08-13 |
human |
| Fatemeh Mohammadi-Milasi, Karim Mahnam, Mostafa Shakhsi-Niae. In silico study of the association of the HLA-A*31:01 allele (human leucocyte antigen allele 31:01) with neuroantigenic epitopes of PLP (proteolipid protein), MBP (myelin basic protein) and MOG proteins (myelin oligodendrocyte glycoprotein) for studying the multiple sclerosis disease pathogenesis. Journal of biomolecular structure & dynamics. vol 39. issue 7. 2021-07-02. PMID:32242486. |
plp (proteolipid protein), mpb (myelin basic protein), and myelin oligodendrocyte glycoprotein (mog) proteins are important autoantigens for the demyelinating of cns in multiple sclerosis. |
2021-07-02 |
2023-08-13 |
human |
| Rina Aharoni, Renana Globerman, Raya Eilam, Ori Brenner, Ruth Arno. Titration of myelin oligodendrocyte glycoprotein (MOG) - Induced experimental autoimmune encephalomyelitis (EAE) model. Journal of neuroscience methods. vol 351. 2021-06-30. PMID:33189793. |
experimental autoimmune encephalomyelitis (eae) induced by the myelin oligodendrocyte glycoprotein (mog) peptide 35-55, is a widely used multiple sclerosis (ms) model. |
2021-06-30 |
2023-08-13 |
mouse |
| Rita Mathews, L Ramy. A comparative study for the intermediate states of myelin oligodendrocyte glycoprotein in the absence and presence of glycan - A computational approach. Journal of molecular graphics & modelling. vol 96. 2021-06-21. PMID:31881468. |
myelin oligodendrocyte glycoprotein (mog) is found to play an important role in providing structural integrity to myelin sheath at the same time it acts as an auto-antigen which might lead to multiple sclerosis (ms). |
2021-06-21 |
2023-08-13 |
Not clear |
| Dhaval Dave, Furqan Khan, Shalesh Rohatgi, Satish Nirhale, Prajwal Rao, Pravin Naphad. Atypical Multiple Sclerosis with Antibody to MOG. Neurology India. vol 68. issue 5. 2021-06-21. PMID:33109887. |
she also turned out to be positive for anti-myelin oligodendrocyte glycoprotein (mog) antibody; hence, she was diagnosed with atypical multiple sclerosis. |
2021-06-21 |
2023-08-13 |
Not clear |
| Matteo Gastaldi, Silvia Scaranzin, Sven Jarius, Brigitte Wildeman, Elisabetta Zardini, Giulia Mallucci, Eleonora Rigoni, Elisa Vegezzi, Thomas Foiadelli, Salvatore Savasta, Paola Banfi, Maurizio Versino, Luana Benedetti, Giovanni Novi, Margherita Maria Mancardi, Thea Giacomini, Pietro Annovazzi, Damiano Baroncini, Diana Ferraro, Vito Lampasona, Markus Reindl, Patrick Waters, Diego Franciott. Cell-based assays for the detection of MOG antibodies: a comparative study. Journal of neurology. vol 267. issue 12. 2021-06-18. PMID:32623596. |
the detection of antibodies to myelin oligodendrocyte glycoprotein (mog) is fundamental for the identification of mog antibody-associated disorders (mogad), and the differential diagnosis of acquired demyelinating syndromes of the cns, among which multiple sclerosis (ms). |
2021-06-18 |
2023-08-13 |
Not clear |
| Rino Vicini, Dominik Brügger, Mathias Abegg, Anke Salmen, Hilary Michelle Grab. Differences in morphology and visual function of myelin oligodendrocyte glycoprotein antibody and multiple sclerosis associated optic neuritis. Journal of neurology. vol 268. issue 1. 2021-06-18. PMID:32785840. |
differences in morphology and visual function of myelin oligodendrocyte glycoprotein antibody and multiple sclerosis associated optic neuritis. |
2021-06-18 |
2023-08-13 |
Not clear |
| Sheng Zhang, Yan Wang, Xiaoqing Zhu, Lanying Song, Xinhua Zhan, Edric Ma, Jennifer McDonough, Hui Fu, Franca Cambi, Judith Grinspan, Fuzheng Gu. The Wnt Effector TCF7l2 Promotes Oligodendroglial Differentiation by Repressing Autocrine BMP4-Mediated Signaling. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 41. issue 8. 2021-06-14. PMID:33452226. |
promoting oligodendrocyte (ol) differentiation represents a promising option for remyelination therapy for treating the demyelinating disease multiple sclerosis (ms). |
2021-06-14 |
2023-08-13 |
mouse |
| Jacopo Angelini, Davide Marangon, Stefano Raffaele, Davide Lecca, Maria P Abbracchi. The Distribution of GPR17-Expressing Cells Correlates with White Matter Inflammation Status in Brain Tissues of Multiple Sclerosis Patients. International journal of molecular sciences. vol 22. issue 9. 2021-06-03. PMID:33925469. |
in multiple sclerosis (ms), oligodendrocyte precursor cells (opcs) are recruited to the site of injury to remyelinate damaged axons; however, in patients this process is often ineffective due to defects in opc maturation. |
2021-06-03 |
2023-08-13 |
human |
| Katsushi Katayama, Tsutomu Nagata, Kouhei Takashima, Ayako Yoshida, Hiroyuki Okada, Yoshiaki Oyama, Tsuyoshi Mut. Design, synthesis, and biological evaluation of spiroindolines as novel inducers of oligodendrocyte progenitor cell differentiation-Use of a conformation-based hypothesis to facilitate compound design. Bioorganic & medicinal chemistry letters. vol 30. issue 16. 2021-05-28. PMID:32631519. |
inducing oligodendrocyte progenitor cell (opc) differentiation is a novel therapeutic strategy for the treatment of demyelinating diseases such as multiple sclerosis (ms). |
2021-05-28 |
2023-08-13 |
Not clear |
| Maya Golan, Avivit Krivitsky, Karin Mausner-Fainberg, Moshe Benhamou, Ifat Vigiser, Keren Regev, Hadar Kolb, Arnon Karn. Increased Expression of Ephrins on Immune Cells of Patients with Relapsing Remitting Multiple Sclerosis Affects Oligodendrocyte Differentiation. International journal of molecular sciences. vol 22. issue 4. 2021-05-27. PMID:33671716. |
increased expression of ephrins on immune cells of patients with relapsing remitting multiple sclerosis affects oligodendrocyte differentiation. |
2021-05-27 |
2023-08-13 |
Not clear |
| P Chaudhary, G H Marracci, E Calkins, E Pocius, A L Bensen, T S Scanlan, B Emery, D N Bourdett. Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE. Journal of neuroimmunology. vol 352. 2021-05-21. PMID:33422763. |
thyromimetics thus might protect against oligodendrocyte death, demyelination and axonal degeneration as well as stimulate remyelination in multiple sclerosis. |
2021-05-21 |
2023-08-13 |
mouse |
| Nadjet Gacem, Brahim Nait-Oumesma. Oligodendrocyte Development and Regenerative Therapeutics in Multiple Sclerosis. Life (Basel, Switzerland). vol 11. issue 4. 2021-05-18. PMID:33918664. |
oligodendrocyte development and regenerative therapeutics in multiple sclerosis. |
2021-05-18 |
2023-08-13 |
Not clear |
| Anna S Tolmacheva, Kseniya S Aulova, Andrey E Urusov, Irina A Orlovskaya, Georgy A Nevinsk. Increase in Autoantibodies-Abzymes with Peroxidase and Oxidoreductase Activities in Experimental Autoimmune Encephalomyelitis Mice during the Development of EAE Pathology. Molecules (Basel, Switzerland). vol 26. issue 7. 2021-05-17. PMID:33916567. |
the exact mechanisms of multiple sclerosis (ms) development are still unknown, but the development of experimental autoimmune encephalomyelitis (eae) in c57bl/6 mice is associated with the violation of bone marrow hematopoietic stem cells (hscs) differentiation profiles associated with the production of harmful for human's autoantibodies hydrolyzing myelin basic protein, myelin oligodendrocyte glycoprotein (mog |
2021-05-17 |
2023-08-13 |
mouse |
| John R Ciotti, Noah S Eby, Gregory F Wu, Robert T Naismith, Salim Chahin, Anne H Cros. Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica. Multiple sclerosis and related disorders. vol 45. 2021-05-14. PMID:32702642. |
antibodies to myelin oligodendrocyte glycoprotein (mog) are associated with a cns inflammatory disorder distinct from multiple sclerosis (ms) and aquaporin-4 antibody-positive neuromyelitis optica (nmo). |
2021-05-14 |
2023-08-13 |
Not clear |
| Paul M Elsbernd, William R Hoffman, Jonathan L Carter, Dean M Wingerchu. Interleukin-6 inhibition with tocilizumab for relapsing MOG-IgG associated disorder (MOGAD): A case-series and review. Multiple sclerosis and related disorders. vol 48. 2021-05-14. PMID:33360264. |
myelin oligodendrocyte glycoprotein-immunoglobulin g (mog-igg) associated disorder (mogad) is a cns demyelinating disease distinct from neuromyelitis optica spectrum disorder (nmosd) and multiple sclerosis. |
2021-05-14 |
2023-08-13 |
Not clear |
| Juliane Weber, Nora Bernsdorff, Tilman Robinson, Dominique Endres, Sebastian Rauer, Benjamin Berge. Diagnosis of multiple sclerosis in times of MOG and AQP4 autoantibody testing - A monocentric study. Journal of the neurological sciences. vol 421. 2021-05-14. PMID:33360733. |
myelin oligodendrocyte glycoprotein-igg-associated encephalomyelitis (mog-em) and neuromyelitis optica spectrum disorders are challenging differential diagnoses of multiple sclerosis (ms). |
2021-05-14 |
2023-08-13 |
Not clear |